SCHEMBL10169024

SCHEMBL10169024

C=C1OB(c2cncc(N3CCOCC3)n2)OC1(C)C

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.33
MEN1 O00255 2/20 0.33
ALDH1A1 P00352 2/20 0.33
HPGD P15428 2/20 0.33
KDM4E B2RXH2 1/20 0.33
LMNA P02545 1/20 0.33
GAA P10253 1/20 0.33
MAPT P10636 1/20 0.33
HTT P42858 1/20 0.33
RECQL P46063 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
CRHBP P24387 1/20 0.32
CRHR2 Q13324 1/20 0.32
PIM2 Q9P1W9 1/20 0.31
CYP11B1 P15538 1/20 0.31
CYP11B2 P19099 1/20 0.31
POLB P06746 1/20 0.31
CCNC P24863 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10137342 0.82 KMT2A (0.37) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL12466734 0.76 ALDH1A1 (0.43) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL12314379 0.76 CCR6 (0.36) ALDH1A1KDM4EMAPTSMN1; SMN2CYP11B1
SCHEMBL12314766 0.72 PIK3CA (0.42) KMT2AMEN1ALDH1A1HTTSMN1; SMN2
SCHEMBL13978070 0.71
SCHEMBL31015657 0.71 PDE10A (0.34) KMT2AMEN1ALDH1A1HPGDKDM4E
SCHEMBL13441960 0.70 POLB (0.37) KMT2AALDH1A1KDM4EHSD17B10POLB
SCHEMBL10169023 0.69 HRH4 (0.35) ALDH1A1CYP1A2CYP2C9
SCHEMBL10137347 0.69 HRH4 (0.39) ALDH1A1KDM4EHSD17B10PIM2CYP11B1
SCHEMBL12316019 0.68 PRMT6 (0.36) KMT2AMEN1ALDH1A1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8168651-B2 Protein kinase modulators CYLENE PHARMACEUTICALS, INC. (US) 2012-05-01 US disclosed
US-20090239859-A1 PROTEIN KINASE MODULATORS SENHWA BIOSCIENCES, INC. (TW) 2009-09-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090239859-A1 PROTEIN KINASE MODULATORS PIM1, PIM2, PIM3 KMT2A 1381/4885MEN1 3739/4885ALDH1A1 3801/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.